0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-328
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Biosimilar Monoclonal Antibodies Market Insights Forecast to 2025

Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2025

Code: QYRE-Auto-328
Report
May 2019
118 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.
Biosimilar Monoclonal Antibodies is widely used for Oncology, Autoimmune Disease and Others. The most proportion of Biosimilar Monoclonal Antibodies is sales in Autoimmune Disease, and the consumption proportion is about 85.6% in 2017.
The global Biosimilar Monoclonal Antibodies market is valued at 2750 million US$ in 2018 and will reach 15200 million US$ by the end of 2025, growing at a CAGR of 27.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosimilar Monoclonal Antibodies market based on company, product type, end user and key regions.

This report studies the global market size of Biosimilar Monoclonal Antibodies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Monoclonal Antibodies in these regions.
This research report categorizes the global Biosimilar Monoclonal Antibodies market by top players/brands, region, type and end user. This report also studies the global Biosimilar Monoclonal Antibodies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Celltrion
    Pfizer (Hospira)
    3SBIO
    Novartis (Sandoz)
    Dr Reddy’s
    Celgen Biopharma
    Cadila Healthcare
    Hisun Pharma
    Torrent Pharmaceuticals

Market size by Product
    Infliximab
    Rituximab
    Trastuzumab
    Adalimumab
    Other
Market size by End User
    Oncology
    Autoimmune Disease
    Other

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Biosimilar Monoclonal Antibodies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Biosimilar Monoclonal Antibodies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar Monoclonal Antibodies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Biosimilar Monoclonal Antibodies Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Product
        1.4.2 Infliximab
        1.4.3 Rituximab
        1.4.4 Trastuzumab
        1.4.5 Adalimumab
        1.4.6 Other
    1.5 Market by End User
        1.5.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by End User
        1.5.2 Oncology
        1.5.3 Autoimmune Disease
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Biosimilar Monoclonal Antibodies Market Size
        2.1.1 Global Biosimilar Monoclonal Antibodies Revenue 2014-2025
        2.1.2 Global Biosimilar Monoclonal Antibodies Sales 2014-2025
    2.2 Biosimilar Monoclonal Antibodies Growth Rate by Regions
        2.2.1 Global Biosimilar Monoclonal Antibodies Sales by Regions
        2.2.2 Global Biosimilar Monoclonal Antibodies Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers
        3.1.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers
        3.1.2 Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers
        3.1.3 Global Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
    3.2 Biosimilar Monoclonal Antibodies Revenue by Manufacturers
        3.2.1 Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
        3.2.2 Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
    3.3 Biosimilar Monoclonal Antibodies Price by Manufacturers
    3.4 Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Product Types
        3.4.1 Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Biosimilar Monoclonal Antibodies Product Type
        3.4.3 Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Biosimilar Monoclonal Antibodies Sales by Product
    4.2 Global Biosimilar Monoclonal Antibodies Revenue by Product
    4.3 Biosimilar Monoclonal Antibodies Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Biosimilar Monoclonal Antibodies Breakdown Data by End User

6 North America
    6.1 North America Biosimilar Monoclonal Antibodies by Countries
        6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Countries
        6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Biosimilar Monoclonal Antibodies by Product
    6.3 North America Biosimilar Monoclonal Antibodies by End User

7 Europe
    7.1 Europe Biosimilar Monoclonal Antibodies by Countries
        7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Countries
        7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Biosimilar Monoclonal Antibodies by Product
    7.3 Europe Biosimilar Monoclonal Antibodies by End User

8 Asia Pacific
    8.1 Asia Pacific Biosimilar Monoclonal Antibodies by Countries
        8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries
        8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Biosimilar Monoclonal Antibodies by Product
    8.3 Asia Pacific Biosimilar Monoclonal Antibodies by End User

9 Central & South America
    9.1 Central & South America Biosimilar Monoclonal Antibodies by Countries
        9.1.1 Central & South America Biosimilar Monoclonal Antibodies Sales by Countries
        9.1.2 Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Biosimilar Monoclonal Antibodies by Product
    9.3 Central & South America Biosimilar Monoclonal Antibodies by End User

10 Middle East and Africa
    10.1 Middle East and Africa Biosimilar Monoclonal Antibodies by Countries
        10.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries
        10.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Biosimilar Monoclonal Antibodies by Product
    10.3 Middle East and Africa Biosimilar Monoclonal Antibodies by End User

11 Company Profiles
    11.1 Celltrion
        11.1.1 Celltrion Company Details
        11.1.2 Company Business Overview
        11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
        11.1.5 Celltrion Recent Development
    11.2 Pfizer (Hospira)
        11.2.1 Pfizer (Hospira) Company Details
        11.2.2 Company Business Overview
        11.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
        11.2.5 Pfizer (Hospira) Recent Development
    11.3 3SBIO
        11.3.1 3SBIO Company Details
        11.3.2 Company Business Overview
        11.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered
        11.3.5 3SBIO Recent Development
    11.4 Novartis (Sandoz)
        11.4.1 Novartis (Sandoz) Company Details
        11.4.2 Company Business Overview
        11.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
        11.4.5 Novartis (Sandoz) Recent Development
    11.5 Dr Reddy’s
        11.5.1 Dr Reddy’s Company Details
        11.5.2 Company Business Overview
        11.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered
        11.5.5 Dr Reddy’s Recent Development
    11.6 Celgen Biopharma
        11.6.1 Celgen Biopharma Company Details
        11.6.2 Company Business Overview
        11.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
        11.6.5 Celgen Biopharma Recent Development
    11.7 Cadila Healthcare
        11.7.1 Cadila Healthcare Company Details
        11.7.2 Company Business Overview
        11.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
        11.7.5 Cadila Healthcare Recent Development
    11.8 Hisun Pharma
        11.8.1 Hisun Pharma Company Details
        11.8.2 Company Business Overview
        11.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
        11.8.5 Hisun Pharma Recent Development
    11.9 Torrent Pharmaceuticals
        11.9.1 Torrent Pharmaceuticals Company Details
        11.9.2 Company Business Overview
        11.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
        11.9.5 Torrent Pharmaceuticals Recent Development

12 Future Forecast
    12.1 Biosimilar Monoclonal Antibodies Market Forecast by Regions
        12.1.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2019-2025
        12.1.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2019-2025
    12.2 Biosimilar Monoclonal Antibodies Market Forecast by Product
        12.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Product 2019-2025
        12.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Product 2019-2025
    12.3 Biosimilar Monoclonal Antibodies Market Forecast by End User
    12.4 North America Biosimilar Monoclonal Antibodies Forecast
    12.5 Europe Biosimilar Monoclonal Antibodies Forecast
    12.6 Asia Pacific Biosimilar Monoclonal Antibodies Forecast
    12.7 Central & South America Biosimilar Monoclonal Antibodies Forecast
    12.8 Middle East and Africa Biosimilar Monoclonal Antibodies Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Biosimilar Monoclonal Antibodies Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Biosimilar Monoclonal Antibodies Product Picture
    Table Biosimilar Monoclonal Antibodies Market Segments
    Table Key Manufacturers Biosimilar Monoclonal Antibodies Covered
    Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product 2014-2025
    Figure Infliximab Product Picture
    Table Major Manufacturers of Infliximab
    Figure Rituximab Product Picture
    Table Major Manufacturers of Rituximab
    Figure Trastuzumab Product Picture
    Table Major Manufacturers of Trastuzumab
    Figure Adalimumab Product Picture
    Table Major Manufacturers of Adalimumab
    Figure Other Product Picture
    Table Major Manufacturers of Other
    Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Oncology
    Figure Autoimmune Disease
    Figure Other
    Figure Biosimilar Monoclonal Antibodies Report Years Considered
    Figure Global Biosimilar Monoclonal Antibodies Market Size 2014-2025 (Million US$)
    Figure Global Biosimilar Monoclonal Antibodies Sales 2014-2025 (K Units)
    Table Global Biosimilar Monoclonal Antibodies Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Biosimilar Monoclonal Antibodies Sales by Regions 2014-2019 (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2014-2019
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2014-2019
    Figure 2018 Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions
    Table Global Biosimilar Monoclonal Antibodies Revenue by Regions 2014-2019 (Million US$)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions
    Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2014-2019) (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2014-2019) (Million USD)
    Table Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
    Figure Biosimilar Monoclonal Antibodies Value Share by Manufacturers in 2018
    Table Key Manufacturers Biosimilar Monoclonal Antibodies Price (2014-2019) (USD/Unit)
    Table Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Biosimilar Monoclonal Antibodies Product Type
    Table Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Share by Product (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue by Product (2014-2019) (Million US$)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Product (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Product (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Product in 2018
    Table Biosimilar Monoclonal Antibodies Price by Product 2014-2019 (USD/Unit)
    Table Global Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Share by End User (2014-2019)
    Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by End User (2014-2019)
    Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by End User in 2018
    Figure North America Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
    Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
    Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries
    Table North America Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
    Table North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
    Figure United States Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure United States Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure 2018 North America Biosimilar Monoclonal Antibodies Market Share by Product
    Table North America Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table North America Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
    Figure 2018 North America Biosimilar Monoclonal Antibodies Market Share by End User
    Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
    Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries
    Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
    Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
    Figure Germany Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure France Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure UK Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Biosimilar Monoclonal Antibodies Market Share by Product
    Table Europe Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Biosimilar Monoclonal Antibodies Market Share by End User
    Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries
    Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
    Figure China Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Product
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Market Share by End User
    Figure Central & South America Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
    Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries
    Table Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
    Figure Brazil Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Market Share by Product
    Table Central & South America Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Market Share by End User
    Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
    Figure GCC Countries Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by Product
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by End User
    Table Celltrion Company Details
    Table Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Celltrion Recent Development
    Table Pfizer (Hospira) Company Details
    Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pfizer (Hospira) Recent Development
    Table 3SBIO Company Details
    Table 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table 3SBIO Recent Development
    Table Novartis (Sandoz) Company Details
    Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis (Sandoz) Recent Development
    Table Dr Reddy’s Company Details
    Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Dr Reddy’s Recent Development
    Table Celgen Biopharma Company Details
    Table Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Celgen Biopharma Recent Development
    Table Cadila Healthcare Company Details
    Table Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Cadila Healthcare Recent Development
    Table Hisun Pharma Company Details
    Table Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Hisun Pharma Recent Development
    Table Torrent Pharmaceuticals Company Details
    Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Torrent Pharmaceuticals Recent Development
    Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions 2019-2025
    Table Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions 2019-2025
    Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Product 2019-2025 (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Product 2019-2025
    Table Global Biosimilar Monoclonal Antibodies Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Product 2019-2025
    Table Global Biosimilar Monoclonal Antibodies Sales Forecast by End User 2019-2025 (K Units)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by End User 2019-2025
    Figure North America Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Biosimilar Monoclonal Antibodies Value Chain
    Table Biosimilar Monoclonal Antibodies Customers List
    Table Biosimilar Monoclonal Antibodies Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and China Elspar Market Insights Forecast to 2027
Global and China Elspar Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-9G6884
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and United States Clofarabine Drugs Market Insights Forecast to 2027
Global and United States Clofarabine Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-0G7032
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and Japan Dasatinib Drugs Market Insights Forecast to 2027
Global and Japan Dasatinib Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-26C6576
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Independent Clinical Laboratories ICL Market Insights Forecast to 2027
Global and China Independent Clinical Laboratories (ICL) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30O6445
Sun Sep 05 00:00:00 UTC 2021

Add to Cart